StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$8.74−0.74 (-7.81%)

Close on Nov 18, 2026Market cap $349.60MP/E –Yield –

Adlai Nortye r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $32.83M, down 26.9% from the year before. The highest annual figure on record is $58.15M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.83M-26.9%
FY2024Dec 31, 2024$44.92M-22.8%
FY2023Dec 31, 2023$58.15M+6.7%
FY2022Dec 31, 2022$54.49M+29.4%
FY2021Dec 31, 2021$42.11M–

More Adlai Nortye figures

See a number that looks wrong?